This post is from a suggested group
Understanding Keytruda in the U.S.: A Transformative Approach to Cancer Care
Keytruda, known generically as pembrolizumab, has become one of the most widely recognized immunotherapy treatments in the United States due to its role in changing how several cancers are treated. Unlike traditional chemotherapy, which directly attacks cancer cells but may also harm healthy tissue, Keytruda uses a more targeted approach by empowering the body’s own immune system. This shift has given many patients new options, especially those whose cancers were once considered difficult to treat.
In the U.S., Keytruda is approved for a broad range of cancers including melanoma, lung cancer, head and neck cancers, bladder cancer, cervical cancer, and certain types of gastrointestinal cancers, among others. One of the most groundbreaking aspects of Keytruda’s approval history is that it was the first cancer treatment in the country authorized based on a tumor’s genetic features rather than its location…